Independent report

Vivaldi 3: coronavirus (COVID-19) antibody and cellular immune response in care homes study report

Report setting out the results of a study of 202 staff and 286 residents in care homes undertaken between December 2020 and June 2021.

• From: UK Health Security Agency
• Published: 10 December 2021

Documents

Vivaldi 3: reduced antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities

HTML

Details

The Vivaldi 3 study, conducted by the University of Birmingham in collaboration with University College London, is an integral part of the Vivaldi project which was set up in June 2020 to investigate SARS-CoV-2 transmission, infection outcomes and immunity in residents and staff in care homes in England.

Published 10 December 2021